Diabetes Mellitus: all 11,090 studies

Page 20 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)CompletedNCT02906709Phase 4Results posted
• A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and HypertensionCompletedNCT02906579Phase 2Results posted
• Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.CompletedNCT02904512Not applicableResults posted
• Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes MellitusCompletedNCT02891382Not applicableResults posted
• Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes MellitusCompletedNCT02889510Phase 3Results posted
• Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 DiabetesCompletedNCT02888691Not applicableResults posted
• Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)CompletedNCT02879383Not applicableResults posted
• Strengths-Based Behavioral mHealth App for Parents of Adolescents With Type 1 Diabetes-Pilot StudyCompletedNCT02877680Not applicableResults posted
• Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes MellitusCompletedNCT02871882Phase 2Results posted
• The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)CompletedNCT02867436Not applicableResults posted
• Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 InhibitorsCompletedNCT02864914Results posted
• COMRADE: Collaborative Care Management for Distress and Depression in Rural DiabetesCompletedNCT02863523Not applicableResults posted
• Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT02863419Phase 3Results posted
• Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes MellitusCompletedNCT02863328Phase 3Results posted
• Phase 3 Alogliptin Pediatric StudyCompletedNCT02856113Phase 3Results posted
• Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.CompletedNCT02849080Phase 3Results posted
• JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes MellitusCompletedNCT02848833Results posted
• Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With DiabetesCompletedNCT02846779Not applicableResults posted
• A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 DiabetesCompletedNCT02846545Phase 2Results posted
• Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?CompletedNCT02846233Not applicableResults posted
• Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentCompletedNCT02836873Phase 3Results posted
• Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot StudyCompletedNCT02835495Not applicableResults posted
• A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram SyndromeCompletedNCT02829268Phase 1/2Results posted
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT02827708Phase 3Results posted
• Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesCompletedNCT02825251Phase 3Results posted
• A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 DiabetesCompletedNCT02814838Phase 2Results posted
• Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in IndiaCompletedNCT02813668Not applicableResults posted
• A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
• A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
• Twitter and DiabetesCompletedNCT02806700Not applicableResults posted
• Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 DiabetesCompletedNCT02804932Not applicableResults posted
• Immune Profile in Subjects With New Onset Type 1 DiabetesCompletedNCT02801942Not applicableResults posted
• Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 DiabetesCompletedNCT02796170Phase 4Results posted
• An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02793154Phase 4Results posted
• A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)CompletedNCT02791490Phase 3Results posted
• A Patient-Centered PaTH to Addressing DiabetesCompletedNCT02788903Results posted
• Sleep Promotion to Improve Diabetes Management in Adolescents With T1DCompletedNCT02786953Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 DiabetesCompletedNCT02784275Phase 2Results posted
• Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care PatientsCompletedNCT02779556Not applicableResults posted
• Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 DiabetesCompletedNCT02777073Not applicableResults posted
• A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusCompletedNCT02773368Phase 3Results posted
• Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes MellitusCompletedNCT02772783Not applicableResults posted
• An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02771093Phase 4Results posted
• EndoBarrier in Obese Subjects With Type 2 Diabetes MellitusCompletedNCT02769728Not applicableResults posted
• Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedNCT02769481Phase 3Results posted
• The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 DiabetesCompletedNCT02762708Phase 2Results posted
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 DiabetesCompletedNCT02762578Phase 3Results posted
• Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 DiabetesCompletedNCT02762370Phase 2Results posted
• A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)CompletedNCT02759107Phase 1Results posted
• Diabetes and Glycosylation in Cervical SpondylosisTerminatedNCT02758899Results posted
• An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2CompletedNCT02756832Results posted
• YH1 in Poorly Controlled Type 2 DiabetesCompletedNCT02752880Phase 2/3Results posted
• Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02750930Phase 4Results posted
• A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCompletedNCT02750410Phase 4Results posted
• Closed-Loop Control in Young Children 5-8 Years Old Using DiAs PlatformCompletedNCT02750267Not applicableResults posted
• Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed DyslipidemiaCompletedNCT02739984Phase 3Results posted
• Randomized Sitagliptin Withdrawal Study (MK-0431-845)CompletedNCT02738879Phase 3Results posted
• Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCompletedNCT02738151Phase 4Results posted
• Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes MellitusCompletedNCT02737891Phase 2Results posted
• Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes MellitusCompletedNCT02737722Phase 1/2Results posted
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT02735044Phase 3Results posted
• Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 DiabetesCompletedNCT02734667Not applicableResults posted
• Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 DiabetesCompletedNCT02733991Not applicableResults posted
• Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesCompletedNCT02730377Phase 4Results posted
• Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)CompletedNCT02722499Not applicableResults posted
• The LoBAG Diet and Type 2 Diabetes MellitusCompletedNCT02717078Not applicableResults posted
• Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesCompletedNCT02715258Phase 3Results posted
• Anti-inflammatory Therapy to Improve Outcomes After TPIATCompletedNCT02713997Phase 4Results posted
• Impact of Medicaid Health Home on Patients With Diabetes in New York CityCompletedNCT02713321Results posted
• A Study of the GI Sleeve for the Treatment of Type 2 DiabetesCompletedNCT02709577Phase 1/2Results posted
• A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyCompletedNCT02703350Phase 1Results posted
• A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCompletedNCT02703337Phase 1Results posted
• A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsCompletedNCT02703324Phase 1Results posted
• Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes MellitusCompletedNCT02702011Phase 2Results posted
• A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesCompletedNCT02692716Phase 3Results posted
• Study of the Gut Hormone Analogue G3215 in Adult SubjectsCompletedNCT02692040Phase 1Results posted
• Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)CompletedNCT02691247Phase 2Results posted
• Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes MellitusCompletedNCT02683746Phase 3Results posted
• Renoprotective Effects of Dapagliflozin in Type 2 DiabetesCompletedNCT02682563Phase 4Results posted
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 DiabetesCompletedNCT02681094Phase 3Results posted
• Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02680457Phase 4Results posted
• Additional Insulin for Fat and Protein in Children With Diabetes StudyTerminatedNCT02680054Phase 4Results posted
• Improving Health in Diabetes ProjectCompletedNCT02672176Not applicableResults posted
• Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 DiabetesTerminatedNCT02671136Not applicableResults posted
• Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.CompletedNCT02670928Phase 4Results posted
• Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 DiabetesCompletedNCT02670915Phase 3Results posted
• Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsCompletedNCT02666430Phase 3Results posted
• FreeStyle Libre in Pregnancy StudyCompletedNCT02665455Not applicableResults posted
• Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 DiabetesCompletedNCT02660827Not applicableResults posted
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesCompletedNCT02660242Phase 2Results posted
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After RamadanCompletedNCT02648217Phase 3Results posted
• Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.CompletedNCT02648204Phase 3Results posted
• 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on MetforminCompletedNCT02647320Phase 2Results posted
• The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic NeuropathyCompletedNCT02643251Phase 2Results posted
• The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes MellitusCompletedNCT02643225Results posted
• Modulation of STAT3 Signaling With Siltuximab in Type 1 DiabetesCompletedNCT02641522Early Phase 1Results posted
• Effect of DPP4 Inhibition on VasoconstrictionCompletedNCT02639637Phase 4Results posted
• Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice ExperimentCompletedNCT02637622Results posted
• Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingCompletedNCT02637609Results posted
• Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN StudyCompletedNCT02632747Phase 2Results posted

← Diabetes Mellitus overview